Literature DB >> 2419362

Nature of the glomerular capillary injury in human membranous glomerulopathy.

O Shemesh, J C Ross, W M Deen, G W Grant, B D Myers.   

Abstract

A differential solute clearance technique was used to evaluate glomerular capillary wall function in 20 patients with membranous glomerulopathy and massive proteinuria. The clearance of inulin, the filtration fraction, and the fractional clearance of uncharged dextrans of a radius of 28-48 A were depressed significantly below control values in 20 healthy volunteers (P less than 0.01). In contrast, the fractional clearance of dextrans of radius greater than 50 A was elevated markedly. A theoretical model of solute transport that depicts the major portion of the glomerular capillary wall as an isoporous membrane and the minor portion as a nondiscriminatory shunt pathway revealed the calculated glomerular ultrafiltration coefficient to be five times lower and mean pore radius of the major membrane component to be 4 A smaller than control values. However, the fraction of filtrate volume permeating the shunt pathway was three- to fourfold above control values and correlated strongly in individual patients with the fractional clearance of albumin (r = 0.76) and of IgG (r = 0.80). Lowering renal plasma flow by 24% during indomethacin therapy in seven patients resulted in a 74% reduction in proteinuria accompanied by a corresponding diminution of filtrate formed through the shunt pathway. Morphometric analysis of glomerular ultrastructure revealed the magnitude of depression of the glomerular filtration rate and of urinary protein leakage to be related strongly to changes in the epithelial layer of the glomerular capillary wall, but not to the density of subepithelial immune deposits. We conclude that glomerular capillaries in membranous glomerulopathy are characterized by a loss of ultrafiltration capacity and of barrier size-selectivity, and that subepithelial immune deposits do not provide a structural basis for these functional alterations.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2419362      PMCID: PMC423473          DOI: 10.1172/JCI112384

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  The ultrastructure of the glomerular slit diaphragm in autologous immune complex nephritis.

Authors:  E E Schneeberger; W E Grupe
Journal:  Lab Invest       Date:  1976-03       Impact factor: 5.662

2.  Altered glomerular permeability in Munich-Wistar rats with autologous immune complex nephritis.

Authors:  E E Schneeberger; A O'Brien; W E Grupe
Journal:  Lab Invest       Date:  1979-02       Impact factor: 5.662

3.  Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis.

Authors:  B J Van Damme; G J Fleuren; W W Bakker; R L Vernier; P J Hoedemaeker
Journal:  Lab Invest       Date:  1978-04       Impact factor: 5.662

4.  Renal function in renal diseases.

Authors:  S E BRADLEY; G P BRADLEY; C J TYSON; J J CURRY; W D BLAKE
Journal:  Am J Med       Date:  1950-12       Impact factor: 4.965

5.  Glomerular permeability. Ultrastructural studies in New Zealand black/white mice using polyanionic ferritin as a molecular probe.

Authors:  V E Kelley; T Cavallo
Journal:  Lab Invest       Date:  1977-09       Impact factor: 5.662

6.  The clinical course of idiopathic membranous nephropathy.

Authors:  D T Erwin; J V Donadio; K E Holley
Journal:  Mayo Clin Proc       Date:  1973-10       Impact factor: 7.616

7.  A model of glomerular ultrafiltration in the rat.

Authors:  W M Deen; C R Robertson; B M Brenner
Journal:  Am J Physiol       Date:  1972-11

8.  Permselectivity of of the glomerular capillary wall. Studies of experimental glomerulonephritis in the rat using neutral dextran.

Authors:  R L Chang; W M Deen; C R Robertson; C M Bennett; R J Glassock; B M Brenner; J L Troy; I F Ueki; B Rasmussen
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

9.  Structural-functional relationships in diabetic nephropathy.

Authors:  S M Mauer; M W Steffes; E N Ellis; D E Sutherland; D M Brown; F C Goetz
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

10.  Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions.

Authors:  W HEYMANN; D B HACKEL; S HARWOOD; S G WILSON; J L HUNTER
Journal:  Proc Soc Exp Biol Med       Date:  1959-04
View more
  13 in total

1.  Measurement of renal blood flow in human subjects using the ultrasound velocity profiling technique.

Authors:  Ryuichi Takano; Nobuyuki Taniguchi; Kouichi Itoh; Eiji Kusano
Journal:  J Med Ultrason (2001)       Date:  2006-06       Impact factor: 1.314

2.  Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.

Authors:  A Remuzzi; S Puntorieri; C Battaglia; T Bertani; G Remuzzi
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

Review 3.  Membranous nephropathy. Insights from Heymann nephritis.

Authors:  T Cavallo
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

4.  Immunohistochemical study of the membrane attack complex of complement and S-protein in idiopathic and secondary membranous nephropathy.

Authors:  K N Lai; S T Lo; F M Lai
Journal:  Am J Pathol       Date:  1989-09       Impact factor: 4.307

5.  [The significance of eicosanoids in glomerular diseases].

Authors:  R A Stahl
Journal:  Klin Wochenschr       Date:  1986-09-15

6.  "Intact nephrons" as the primary origin of proteinuria in chronic renal disease. Study in the rat model of subtotal nephrectomy.

Authors:  T Yoshioka; H Shiraga; Y Yoshida; A Fogo; A D Glick; W M Deen; J R Hoyer; I Ichikawa
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

7.  Structural basis for reduced glomerular filtration capacity in nephrotic humans.

Authors:  M C Drumond; B Kristal; B D Myers; W M Deen
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

8.  Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans.

Authors:  A Guasch; W M Deen; B D Myers
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

9.  Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy.

Authors:  Piero Ruggenenti; Paolo Cravedi; Maria Chiara Sghirlanzoni; Elena Gagliardini; Sara Conti; Flavio Gaspari; Gianfranco Marchetti; Mauro Abbate; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2008-08-06       Impact factor: 8.237

10.  Outcome of the acute glomerular injury in proliferative lupus nephritis.

Authors:  A Chagnac; B A Kiberd; M C Fariñas; S Strober; R K Sibley; R Hoppe; B D Myers
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.